{'52WeekChange': -0.8350647,
 'SandP52WeekChange': 0.0644362,
 'address1': 'Building 12W',
 'address2': 'Unit 232, 2/F Phase Three Hong Kong Science Park, Pak Shek Kok',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 3.86,
 'askSize': 1400,
 'averageDailyVolume10Day': 155262,
 'averageVolume': 92615,
 'averageVolume10days': 155262,
 'beta': None,
 'beta3Year': None,
 'bid': 3.51,
 'bidSize': 800,
 'bookValue': 0.563,
 'category': None,
 'circulatingSupply': None,
 'city': 'Hong Kong',
 'companyOfficers': [],
 'country': 'Hong Kong',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 3.87,
 'dayLow': 3.53,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -6.433,
 'enterpriseToRevenue': 203.137,
 'enterpriseValue': 108711784,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fax': '852 3953 7711',
 'fiftyDayAverage': 3.714657,
 'fiftyTwoWeekHigh': 22.58,
 'fiftyTwoWeekLow': 1.66,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 4728438,
 'forwardEps': -0.84,
 'forwardPE': -4.3095236,
 'fromCurrency': None,
 'fullTimeEmployees': 36,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'heldPercentInsiders': 0.3766,
 'heldPercentInstitutions': 0.00013,
 'industry': 'Biotechnology',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': 1304294400,
 'lastSplitFactor': '3:1',
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/aptorumgroup.com',
 'longBusinessSummary': 'Aptorum Group Limited, a pharmaceutical company, '
                        'develops and commercializes a range of therapeutic '
                        'and diagnostic technologies to treat unmet medical '
                        'needs. It focuses on developing various drug '
                        'molecules and certain technologies for the treatment '
                        'and diagnosis of human disease conditions in '
                        'neurology, infectious diseases, gastroenterology, '
                        'oncology, and other disease areas. The company also '
                        'focuses on the development of surgical robotics and '
                        'medical devices; and operating outpatient clinic. '
                        'Aptorum Group Limited has a research and development '
                        'agreement with Covar Pharmaceuticals to investigate 3 '
                        'repurposed drug candidates (SACT-COV19) for '
                        'coronavirus disease under existing Smart-ACT platform '
                        'and Acticule infectious disease platform. Aptorum '
                        'Group Limited was incorporated in 2010 and is '
                        'headquartered in Hong Kong, Hong Kong.',
 'longName': 'Aptorum Group Limited',
 'market': 'us_market',
 'marketCap': 110007088,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_254483578',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1577750400,
 'navPrice': None,
 'netIncomeToCommon': -18686762,
 'nextFiscalYearEnd': 1640908800,
 'open': 3.61,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': None,
 'phone': '852 3953 7700',
 'previousClose': 3.72,
 'priceHint': 4,
 'priceToBook': 6.4298396,
 'priceToSalesTrailing12Months': 205.55695,
 'profitMargins': 0,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 3.87,
 'regularMarketDayLow': 3.53,
 'regularMarketOpen': 3.61,
 'regularMarketPreviousClose': 3.72,
 'regularMarketPrice': 3.61,
 'regularMarketVolume': 115499,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 7950990,
 'sharesPercentSharesOut': 0.001,
 'sharesShort': 30016,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 1007,
 'shortName': 'Aptorum Group Limited',
 'shortPercentOfFloat': 0.0063,
 'shortRatio': 0.21,
 'startDate': None,
 'strikePrice': None,
 'symbol': 'APM',
 'threeYearAverageReturn': None,
 'toCurrency': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -0.644,
 'twoHundredDayAverage': 6.2494893,
 'volume': 115499,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.aptorumgroup.com',
 'yield': None,
 'ytdReturn': None}